57 related articles for article (PubMed ID: 24933002)
1. Common variants of xeroderma pigmentosum genes and prostate cancer risk.
Mirecka A; Paszkowska-Szczur K; Scott RJ; Górski B; van de Wetering T; Wokołorczyk D; Gromowski T; Serrano-Fernandez P; Cybulski C; Kashyap A; Gupta S; Gołąb A; Słojewski M; Sikorski A; Lubiński J; Dębniak T
Gene; 2014 Aug; 546(2):156-61. PubMed ID: 24933002
[TBL] [Abstract][Full Text] [Related]
2. DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.
Dupuy A; Sarasin A
Mutat Res; 2015 Jun; 776():2-8. PubMed ID: 26255934
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract][Full Text] [Related]
4. A unified model for the molecular basis of Xeroderma pigmentosum-Cockayne Syndrome.
Moriel-Carretero M; Herrera-Moyano E; Aguilera A
Rare Dis; 2015; 3(1):e1079362. PubMed ID: 26460500
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide excision repair pathway assessment in DNA exposed to low-intensity red and infrared lasers.
Fonseca AS; Campos VM; Magalhães LA; Paoli F
Braz J Med Biol Res; 2015 Oct; 48(10):929-38. PubMed ID: 26445337
[TBL] [Abstract][Full Text] [Related]
6. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in nucleotide excision repair genes and basal cell carcinoma of the skin.
Pesz KA; Bieniek A; Gil J; Laczmanska I; Karpinski P; Makowska I; Trusewicz A; Sasiadek MM
Int J Dermatol; 2014 Dec; 53(12):1474-7. PubMed ID: 25209577
[TBL] [Abstract][Full Text] [Related]
8. Photobiological Origins of the Field of Genomic Maintenance.
Ganesan A; Hanawalt P
Photochem Photobiol; 2016; 92(1):52-60. PubMed ID: 26481112
[TBL] [Abstract][Full Text] [Related]
9. Xeroderma pigmentosum and leukaemia in two sisters.
Pintens S; Pierret L; Keymolen K; Gutermuth J; De Raeve L
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e42-e43. PubMed ID: 26446056
[No Abstract] [Full Text] [Related]
10. Clinicopathological characteristics of xeroderma pigmentosum associated with keratoacanthoma in an infant.
Han X; Jing H; Liu C; Zheng J
J Cancer Res Ther; 2015; 11(3):665. PubMed ID: 26458699
[TBL] [Abstract][Full Text] [Related]
11. Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts.
Guillermo-Lagae R; Deep G; Ting H; Agarwal C; Agarwal R
Oncotarget; 2015 Nov; 6(37):39594-606. PubMed ID: 26447614
[TBL] [Abstract][Full Text] [Related]
12. Genome Instability in Development and Aging: Insights from Nucleotide Excision Repair in Humans, Mice, and Worms.
Edifizi D; Schumacher B
Biomolecules; 2015 Aug; 5(3):1855-69. PubMed ID: 26287260
[TBL] [Abstract][Full Text] [Related]
13. Overview of xeroderma pigmentosum proteins architecture, mutations and post-translational modifications.
Feltes BC; Bonatto D
Mutat Res Rev Mutat Res; 2015; 763():306-20. PubMed ID: 25795128
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis.
Cybulski C; Kluźniak W; Huzarski T; Wokołorczyk D; Kashyap A; Jakubowska A; Szwiec M; Byrski T; Dębniak T; Górski B; Sopik V; Akbari MR; Sun P; Gronwald J; Narod SA; Lubiński J;
Lancet Oncol; 2015 Jun; 16(6):638-44. PubMed ID: 25959805
[TBL] [Abstract][Full Text] [Related]
15. Germline RECQL mutations are associated with breast cancer susceptibility.
Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study.
Segev Y; Rosen B; Lubinski J; Gronwald J; Lynch HT; Moller P; Kim-Sing C; Ghadirian P; Karlan B; Eng C; Gilchrist D; Neuhausen SL; Eisen A; Friedman E; Euhus D; Ping S; Narod SA;
Fam Cancer; 2015 Sep; 14(3):383-91. PubMed ID: 25838159
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Lee AW; Tyrer JP; Doherty JA; Stram DA; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Spiewankiewicz B; Myers EJ; ; ; Chenevix-Trench G; Fasching PA; Beckmann MW; Ekici AB; Hein A; Vergote I; Van Nieuwenhuysen E; Lambrechts D; Wicklund KG; Eilber U; Wang-Gohrke S; Chang-Claude J; Rudolph A; Sucheston-Campbell L; Odunsi K; Moysich KB; Shvetsov YB; Thompson PJ; Goodman MT; Wilkens LR; Dörk T; Hillemanns P; Dürst M; Runnebaum IB; Bogdanova N; Pelttari LM; Nevanlinna H; Leminen A; Edwards RP; Kelley JL; Harter P; Schwaab I; Heitz F; du Bois A; Orsulic S; Lester J; Walsh C; Karlan BY; Hogdall E; Kjaer SK; Jensen A; Vierkant RA; Cunningham JM; Goode EL; Fridley BL; Southey MC; Giles GG; Bruinsma F; Wu X; Hildebrandt MA; Lu K; Liang D; Bisogna M; Levine DA; Weber RP; Schildkraut JM; Iversen ES; Berchuck A; Terry KL; Cramer DW; Tworoger SS; Poole EM; Olson SH; Orlow I; Bandera EV; Bjorge L; Tangen IL; Salvesen HB; Krakstad C; Massuger LF; Kiemeney LA; Aben KK; van Altena AM; Bean Y; Pejovic T; Kellar M; Le ND; Cook LS; Kelemen LE; Brooks-Wilson A; Lubinski J; Gronwald J; Cybulski C; Jakubowska A; Wentzensen N; Brinton LA; Lissowska J; Yang H; Nedergaard L; Lundvall L; Hogdall C; Song H; Campbell IG; Eccles D; Glasspool R; Siddiqui N; Carty K; Paul J; McNeish IA; Sieh W; McGuire V; Rothstein JH; Whittemore AS; McLaughlin JR; Risch HA; Phelan CM; Anton-Culver H; Ziogas A; Menon U; Ramus SJ; Gentry-Maharaj A; Harrington P; Pike MC; Modugno F; Rossing MA; Ness RB; Pharoah PD; Stram DO; Wu AH; Pearce CL
Gynecol Oncol; 2015 Mar; 136(3):542-8. PubMed ID: 25528498
[TBL] [Abstract][Full Text] [Related]
18. The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men.
Antczak A; Wokołorczyk D; Kluźniak W; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Janiszewska H; Stawicka M; Milecki P; Lubiński J; Narod SA; Cybulski C;
Eur J Cancer Prev; 2015 Mar; 24(2):122-7. PubMed ID: 25187206
[TBL] [Abstract][Full Text] [Related]
19. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
Kelemen LE; Terry KL; Goodman MT; Webb PM; Bandera EV; McGuire V; Rossing MA; Wang Q; Dicks E; Tyrer JP; Song H; Kupryjanczyk J; Dansonka-Mieszkowska A; Plisiecka-Halasa J; Timorek A; Menon U; Gentry-Maharaj A; Gayther SA; Ramus SJ; Narod SA; Risch HA; McLaughlin JR; Siddiqui N; Glasspool R; Paul J; Carty K; Gronwald J; Lubiński J; Jakubowska A; Cybulski C; Kiemeney LA; Massuger LF; van Altena AM; Aben KK; Olson SH; Orlow I; Cramer DW; Levine DA; Bisogna M; Giles GG; Southey MC; Bruinsma F; Kjaer SK; Høgdall E; Jensen A; Høgdall CK; Lundvall L; Engelholm SA; Heitz F; du Bois A; Harter P; Schwaab I; Butzow R; Nevanlinna H; Pelttari LM; Leminen A; Thompson PJ; Lurie G; Wilkens LR; Lambrechts D; Van Nieuwenhuysen E; Lambrechts S; Vergote I; Beesley J; ; Fasching PA; Beckmann MW; Hein A; Ekici AB; Doherty JA; Wu AH; Pearce CL; Pike MC; Stram D; Chang-Claude J; Rudolph A; Dörk T; Dürst M; Hillemanns P; Runnebaum IB; Bogdanova N; Antonenkova N; Odunsi K; Edwards RP; Kelley JL; Modugno F; Ness RB; Karlan BY; Walsh C; Lester J; Orsulic S; Fridley BL; Vierkant RA; Cunningham JM; Wu X; Lu K; Liang D; Hildebrandt MA; Weber RP; Iversen ES; Tworoger SS; Poole EM; Salvesen HB; Krakstad C; Bjorge L; Tangen IL; Pejovic T; Bean Y; Kellar M; Wentzensen N; Brinton LA; Lissowska J; Garcia-Closas M; Campbell IG; Eccles D; Whittemore AS; Sieh W; Rothstein JH; Anton-Culver H; Ziogas A; Phelan CM; Moysich KB; Goode EL; Schildkraut JM; Berchuck A; Pharoah PD; Sellers TA; Brooks-Wilson A; Cook LS; Le ND
Mol Nutr Food Res; 2014 Oct; 58(10):2023-35. PubMed ID: 25066213
[TBL] [Abstract][Full Text] [Related]
20. XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.
Qin F; Gao SL; Xu K; Su QX; Zhang Z; Shi L; Zhu LJ; Zhang LF; Zuo L
Medicine (Baltimore); 2020 Jul; 99(28):e21160. PubMed ID: 32664151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
